Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consisted of CEOs, VPs of Product Development, regulatory affairs chiefs, and commercial directors from denture adhesive manufacturers, dental product OEMs, and oral care products companies. Prosthodontists, general dentists, dental clinic administrators, dental laboratory technicians, medical directors from hospitals and clinics, procurement leads from dental academic and research institutes, and purchasing managers from retail pharmacy chains constituted demand-side sources. Market segmentation was validated, product pipeline timelines were confirmed, and insights regarding clinical adoption patterns, pricing strategies, and distribution channel dynamics were obtained through primary research.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)
By Region: North America (38%), Europe (25%), Asia-Pacific (28%), Rest of World (9%)
Global market valuation was derived through revenue mapping and product volume analysis. The methodology included:
Identification of 35+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America
Product mapping across cream/paste, powder, and other adhesive categories
Analysis of reported and modeled annual revenues specific to denture adhesive portfolios
Coverage of manufacturers representing 70-75% of global market share in 2024
Extrapolation using bottom-up (product volume × ASP by country) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations